Elements toward novel therapeutic targeting of the adrenergic system
drenergic receptors belong to the family of the G protein coupled receptors that represent important targets in the modern pharmacotherapies. Studies on different physiological and pathophysiological properties of the adrenergic system have led to novel evidences and theories that suggest novel possible targeting of such system in a variety of pathologies and disorders, even beyond the classical known therapeutic possibilities. Herein, those advances have been illustrated with selected concepts and different examples. Furthermore, we illustrated the applications and the therapeutic implications that such findings and advances might have in the contexts of experimental pharmacology, therapeutics and clinic. We hope that the content of this work will guide researches devoted to the adrenergic aspects that combine neurosciences with pharmacology. (C) 2014 Elsevier Ltd. All rights reserved.
drenergic receptors belong to the family of the G protein coupled receptors that represent important targets in the modern pharmacotherapies. Studies on different physiological and pathophysiological properties of the adrenergic system have led to novel evidences and theories that suggest novel possible targeting of such system in a variety of pathologies and disorders, even beyond the classical known therapeutic possibilities. Herein, those advances have been illustrated with selected concepts and different examples. Furthermore, we illustrated the applications and the therapeutic implications that such findings and advances might have in the contexts of experimental pharmacology, therapeutics and clinic. We hope that the content of this work will guide researches devoted to the adrenergic aspects that combine neurosciences with pharmacology. (C) 2014 Elsevier Ltd. All rights reserved.
Ghanemi, Abdelaziz、Hu, Xintian、Hu, Xintian、Ghanemi, Abdelaziz
药学基础医学神经病学、精神病学
ENTION-DEFICIT/HYPERACTIVITY DISORDEREFICIT HYPERACTIVITY DISORDEREPIDERMAL-GROWTH-FACTORLONG-TERM POTENTIATIONENTRAL-NERVOUS-SYSTEMPROTEIN-COUPLED RECEPTORBETA(3)-ADRENOCEPTOR AGONIST SR58611ANEONATAL 6-HYDROXYDOPAMINE TREATMENTGUANFACINE EXTENDED-RELEASEWORKING-MEMORY PERFORMANCE
Ghanemi, Abdelaziz,Hu, Xintian,Hu, Xintian,Ghanemi, Abdelaziz.Elements toward novel therapeutic targeting of the adrenergic system[EB/OL].(2016-05-11)[2025-08-02].https://chinaxiv.org/abs/201605.01191.点此复制
评论